首页> 美国卫生研究院文献>Neuro-Oncology >PATH-64. PROSPECTIVE BLINDED PLASMA BASED ANALYSIS FOR DIAGNOSIS OF NEWLY DIAGNOSED GLIOMA
【2h】

PATH-64. PROSPECTIVE BLINDED PLASMA BASED ANALYSIS FOR DIAGNOSIS OF NEWLY DIAGNOSED GLIOMA

机译:Path-64。基于前瞻性的盲血浆的新诊断性胶质瘤的诊断分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In patients with newly diagnosed intracerebral lesions, gliomas are often suspected. However, other conditions such as multiple sclerosis, abscess or lymphoma are possible, as well. Furthermore, biopsy can be challenging due to eloquent and/or deep location within the brain. In this prospective, blinded study, analysis of plasma isolated cell-free DNA and exosome mRNA and miRNA from newly diagnosed glioma patients and from cancer-free volunteers was used to predict disease.
机译:在新诊断的脑内病变患者中,晶瘤通常怀疑。然而,也可以进行其他诸如多发性硬化,脓肿或淋巴瘤的其他条件。此外,由于大脑内的雄性和/或深部位置,活组织检查可能是挑战。在这一前瞻性的,盲化的研究中,使用来自新诊断的胶质瘤和无癌症志愿者的血浆分离的无细胞DNA和外出细胞组和泌尿细胞的分析,从而预测疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号